Mitchell C. Posner to Female
This is a "connection" page, showing publications Mitchell C. Posner has written about Female.
Connection Strength
0.729
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.036
-
Perioperative Gemcitabine?+?Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Ann Surg Oncol. 2019 Dec; 26(13):4489-4497.
Score: 0.034
-
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
Score: 0.027
-
Attitudes and Perceptions of Surgical Oncology Fellows: The Right Voice at the Almost Right Time. Ann Surg Oncol. 2015 Nov; 22(12):3761-3.
Score: 0.026
-
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
Score: 0.025
-
More harm than good? Ann Surg Oncol. 2014 Sep; 21(9):2817-9.
Score: 0.024
-
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012 Feb; 19(2):384-91.
Score: 0.020
-
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer. 2011 Jun 07; 104(12):1896-905.
Score: 0.020
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.015
-
Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases. J Surg Oncol. 2005 Oct 01; 92(1):64-9.
Score: 0.013
-
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant. 2004 Oct; 18(5):502-12.
Score: 0.012
-
Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery. 2003 Oct; 134(4):656-65; discussion 665-6.
Score: 0.011
-
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. JAMA Oncol. 2023 09 01; 9(9):1245-1254.
Score: 0.011
-
Isolated pulmonary recurrence after resection of colorectal hepatic metastases--is resection indicated? Cancer J. 2002 Jul-Aug; 8(4):342-7.
Score: 0.011
-
Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):599-604.
Score: 0.010
-
Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer. Surgery. 2001 Oct; 130(4):620-6; discussion 626-8.
Score: 0.010
-
Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg. 2001 Jul; 136(7):737-42; discussion 743.
Score: 0.010
-
Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
Score: 0.009
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.009
-
Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000 Oct; 128(4):686-93.
Score: 0.009
-
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis. Proc Natl Acad Sci U S A. 2020 09 08; 117(36):22423-22429.
Score: 0.009
-
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000 May; 135(5):530-4; discussion 534-5.
Score: 0.009
-
Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases. Cancer. 2020 01 15; 126(2):281-292.
Score: 0.009
-
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.
Score: 0.009
-
Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model. J Surg Res. 1999 Mar; 82(1):78-87.
Score: 0.008
-
Apoptosis in esophageal cancer following induction chemoradiotherapy. J Surg Res. 1998 Sep; 79(1):20-4.
Score: 0.008
-
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer. 1998 Jul 01; 83(1):7-18.
Score: 0.008
-
Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 1998 Jul-Aug; 4(4):237-46.
Score: 0.008
-
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
Score: 0.008
-
Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr. 1998 Jan-Feb; 22(1):18-21.
Score: 0.008
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.008
-
Is esophagectomy following upfront chemoradiotherapy safe and necessary? Arch Surg. 1997 May; 132(5):481-5; discussion 485-6.
Score: 0.007
-
Chronic hepatitis C virus infection in humans: induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J Surg Res. 1997 May; 69(2):321-4.
Score: 0.007
-
Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017 May 01; 30(5):1-6.
Score: 0.007
-
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases. Mol Ther. 2017 07 05; 25(7):1588-1595.
Score: 0.007
-
Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue. Anticancer Res. 1997 Mar-Apr; 17(2A):1115-23.
Score: 0.007
-
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016 10 24; 6:35854.
Score: 0.007
-
Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1996 May; 91(5):1048-9.
Score: 0.007
-
Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
Score: 0.007
-
Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. Cancer J Sci Am. 1995 Nov-Dec; 1(4):274-80.
Score: 0.007
-
Development and usability testing of a web-based self-management intervention for oral cancer survivors and their family caregivers. Eur J Cancer Care (Engl). 2016 Sep; 25(5):806-21.
Score: 0.007
-
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015 Oct 06; 314(13):1346-55.
Score: 0.007
-
Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
Score: 0.006
-
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014 Jul; 106(7).
Score: 0.006
-
Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014 May; 259(5):960-5.
Score: 0.006
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.006
-
Smooth pursuit eye movements with imaginary targets defined by extrafoveal cues. Vision Res. 1994 Mar; 34(6):803-20.
Score: 0.006
-
Impact of hepatectomy surgical complexity on outcomes and hospital quality rankings. Ann Surg Oncol. 2014 Jun; 21(6):1773-80.
Score: 0.006
-
Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014 May; 21(5):1520-9.
Score: 0.006
-
Indications for breast-preserving surgery and adjuvant therapy in early breast cancer. Int Surg. 1994 Jan-Mar; 79(1):43-7.
Score: 0.006
-
National assessment of margin status as a quality indicator after pancreatic cancer surgery. Ann Surg Oncol. 2014 Apr; 21(4):1067-74.
Score: 0.006
-
Implementing an excellence in teaching recognition system: needs analysis and recommendations. J Surg Educ. 2013 Nov-Dec; 70(6):731-8.
Score: 0.006
-
Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer. J Surg Oncol. 2013 Jun; 107(8):794-8.
Score: 0.006
-
Predictors of unsuccessful laparoscopic resection of gastric submucosal neoplasms. J Gastrointest Surg. 2013 Feb; 17(2):244-55; discussion 255-6.
Score: 0.005
-
Peripheral pulmonary nodules: preoperative percutaneous needle localization with CT guidance. Radiology. 1992 Oct; 185(1):274-6.
Score: 0.005
-
A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol. 2013 Feb; 20(2):533-41.
Score: 0.005
-
A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma. Am J Clin Oncol. 1992 Jun; 15(3):239-41.
Score: 0.005
-
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012 Feb; 75(2):332-8.
Score: 0.005
-
Cavernous hemangioma of the adrenal gland. J Urol. 1992 Jan; 147(1):110-2.
Score: 0.005
-
MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650.
Score: 0.005
-
MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011 Oct; 11(10):2110-22.
Score: 0.005
-
Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation. Mol Cancer Ther. 2011 Jul; 10(7):1185-93.
Score: 0.005
-
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol. 2011 Mar 01; 29(7):934-43.
Score: 0.005
-
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma. Am J Clin Oncol. 1990 Oct; 13(5):455-8.
Score: 0.005
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.005
-
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
Score: 0.005
-
Continuous, data-rich appraisal of surgical trainees' operative abilities: a novel approach for measuring performance and providing feedback. J Surg Educ. 2009 Sep-Oct; 66(5):255-63.
Score: 0.004
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.004
-
The desmoid tumor. Not a benign disease. Arch Surg. 1989 Feb; 124(2):191-6.
Score: 0.004
-
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. Cancer Gene Ther. 2008 Mar; 15(3):133-9.
Score: 0.004
-
Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection. J Hepatobiliary Pancreat Surg. 2007; 14(4):410-3.
Score: 0.004
-
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. J Virol. 2006 Feb; 80(3):1110-20.
Score: 0.003
-
Extrahepatic biliary tract injury: operative management plan. J Trauma. 1985 Sep; 25(9):833-7.
Score: 0.003
-
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma. Cancer Chemother Pharmacol. 2005 Sep; 56(3):317-21.
Score: 0.003
-
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44.
Score: 0.003
-
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay. Am Surg. 2003 Jan; 69(1):24-7.
Score: 0.003
-
Transcriptional control of viral gene therapy by cisplatin. J Clin Invest. 2002 Aug; 110(3):403-10.
Score: 0.003
-
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors. Clin Cancer Res. 2002 Aug; 8(8):2519-23.
Score: 0.003
-
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001 Sep 27; 20(43):6196-204.
Score: 0.002
-
Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, pringle maneuver, and total vascular isolation. Arch Surg. 2001 May; 136(5):569-75.
Score: 0.002
-
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
Score: 0.002
-
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 Dec 15; 60(24):6958-63.
Score: 0.002
-
Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000 Apr; 7(3):188-92.
Score: 0.002
-
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Ann Oncol. 1998 Sep; 9(9):1035-7.
Score: 0.002
-
Thoracoscopic techniques for the management of intrathoracic metastases. Results. Surg Endosc. 1998 Jun; 12(6):842-5.
Score: 0.002
-
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-89-S19-92.
Score: 0.002
-
Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996 Sep; 83(9):1174-85.
Score: 0.002
-
Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract. Surgery. 1996 Jul; 120(1):45-53.
Score: 0.002
-
Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma. Am J Clin Oncol. 1995 Aug; 18(4):300-2.
Score: 0.002
-
A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1139-46.
Score: 0.002
-
Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest. 1995 Feb; 95(2):732-7.
Score: 0.002
-
Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease. Ann Surg Oncol. 1995 Jan; 2(1):49-55.
Score: 0.002
-
Induction with OKT3 and prostaglandin E1 in liver transplantation. Transplant Sci. 1994 Dec; 4 Suppl 1:S1-8.
Score: 0.002
-
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 01; 30(5):1043-50.
Score: 0.002
-
A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg. 1994 Oct; 220(4):436-41; discussion 441-4.
Score: 0.002
-
Needle-localized thoracoscopic resections of small indeterminate pulmonary nodules in transplant patients. Clin Transplant. 1994 Aug; 8(4):378-81.
Score: 0.002
-
Peripheral athero-embolism from the aorta complicating transhiatal esophagectomy. Am Surg. 1994 Aug; 60(8):634-7.
Score: 0.002
-
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.
Score: 0.001
-
Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg. 1993 May; 128(5):559-64.
Score: 0.001
-
Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer. 1993; 29A(4):511-5.
Score: 0.001
-
Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 1992 Nov 15; 52(22):6371-4.
Score: 0.001
-
New method of limb deformities correction in children. Bull N Y Acad Med. 1992 Nov; 68(4):447-69.
Score: 0.001
-
Comparison of immune repertoires of Chinese and Philippine patients infected with Schistosoma japonicum. Infect Immun. 1991 Dec; 59(12):4698-700.
Score: 0.001
-
Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings. AJR Am J Roentgenol. 1991 Sep; 157(3):553-6.
Score: 0.001
-
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):787-91.
Score: 0.001
-
Enrichment culture techniques for selection of cell culture strains with desirable physiological and genetic properties. Acta Endocrinol Suppl (Copenh). 1971; 153:126-36.
Score: 0.000